Rhodamine 123 efflux in drug resistance assays
Pétriz, J.; O'Connor, J.E.; García-López, J.
Leukemia 10(4): 748-749
1996
ISSN/ISBN: 0887-6924 PMID: 8618459 Document Number: 458813
Document emailed within 1 workday
Related Documents
Zhou, W.D.; Zhang, H.Q.; Fang, M.; He, Q.Y.; Pang, D.B.; Xue, S.B. 1996: Induction of expression of MDR 1 gene by retinoic acid and DMSO and effects on rhodamine-123 efflux in HL-60 cell lines and resistant sublines Yao Xue Xue Bao 31(1): 1-5Zinkewich-Péotti, K.; Andrews, P.A. 1992: Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance Cancer Research 52(7): 1902-1906
Deffie, A.M.; Alam, T.; Seneviratne, C.; Beenken, S.W.; Batra, J.K.; Shea, T.C.; Henner, W.D.; Goldenberg, G.J. 1988: Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia Cancer Research 48(13): 3595-3602
Sánchez Díaz, P. 2003: MDR efflux pumps and antimicrobial resistance Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 16(2): 172-187
McIntosh, E.; David, G. 2007: New antibiotics, efflux pumps and overcoming resistance Casopis Lekaru Ceskych 146(2): 102-106; Discussion: 107-108
Zeller, V.; Janoir, C.; Kitzis, M.D.; Gutmann, L.; Moreau, N.J. 1997: Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae Antimicrobial Agents and Chemotherapy 41(9): 1973-1978
Osbild, S.; Brault, L.; Battaglia, E.; Bagrel, D. 2006: Resistance to cisplatin and adriamycin is associated with the inhibition of glutathione efflux in MCF-7-derived cells Anticancer Research 26(5a): 3595-3600
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317
Chojecka, A.; Jakubiec, K.; Jakimiak, B.; Röhm-Rodowald, E.; Kanclerski, K. 2012: Significance of the efflux phenomenon as a mechanism of bacterial resistance on active substances of biocide Przeglad Epidemiologiczny 66(1): 39-44
Choy, B.K.; McClarty, G.A.; Chan, A.K.; Thelander, L.; Wright, J.A. 1988: Molecular mechanisms of drug resistance involving ribonucleotide reductase: hydroxyurea resistance in a series of clonally related mouse cell lines selected in the presence of increasing drug concentrations Cancer Research 48(8): 2029-2035
Hayashi, T.; Yoshimine, N.; Naito, M.; Funaki, C.; Yamada, K.; Asai, K.; Kuzuya, F. 1992: HDL does not promote cholesterol efflux from macrophages of hypercholesterolemic rabbit: efflux differences between species Artery 19(4): 184-198
Matsuoka, M. 2001: Investigation of msrSA gene coding for resistance to macrolide antibiotics by active efflux and its molecular epidemiology Japanese Journal of Antibiotics 54(3): 133-143
Bertagnolio, S.; Rodriguez-Diaz, R.A.; Fuentes-Romero, L.L.; Bennett, D.E.; Viveros-Rogel, M.; Hart, S.; Pilon, R.; Sandstrom, P.; Soto-Ramirez, L.E. 2012: Transmitted HIV drug resistance among drug-naive subjects recently infected with HIV in Mexico City: a World Health Organization survey to classify resistance and to field test two alternative patient enrollment methods Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(Suppl 4): S328-S333
Pazhani, G.P.; Chakraborty, S.; Fujihara, K.; Yamasaki, S.; Ghosh, A.; Nair, G.B.; Ramamurthy, T. 2011: QRDR mutations, efflux system and antimicrobial resistance genes in enterotoxigenic Escherichia coli isolated from an outbreak of diarrhoea in Ahmedabad, India Indian Journal of Medical Research 134: 214-223
Yi, M.-y.; Wang, P.-y.; Huang, H.-j.; Liu, Y.-c. 2006: The roles of active efflux system overexpression and outer membrane protein OprD deficiency or loss in carbapenem resistance of Pseudomonas aeruginosa Zhonghua Yi Xue Za Zhi 86(7): 457-462
Lorico, A.; Rappa, G.; Srimatkandada, S.; Catapano, C.V.; Fernandes, D.J.; Germino, J.F.; Sartorelli, A.C. 1995: Increased rate of adenosine triphosphate-dependent etoposide (VP-16) efflux in a murine leukemia cell line overexpressing the multidrug resistance-associated protein (MRP) gene Cancer Research 55(19): 4352-4360
Mankhetkorn, S.; Dubru, F.; Hesschenbrouck, J.; Fiallo, M.; Garnier-Suillerot, A. 1996: Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells Molecular Pharmacology 49(3): 532-539
Wang, F. 2006: To enhance the research of antibiotic resistance and infection caused by drug-resistance bacteria Zhonghua Yi Xue Za Zhi 86(9): 579-580
Li, J.; Ma, Y.-x.; Zhang, Q.-b.; Zhou, Y.-a.; Shang, R.-p.; Li, P.-l.; Hao, Z.-q. 2013: Correlations of integrons and resistance gene cassettes in Gram-negative bacteria with multi-drug resistance Zhonghua Yi Xue Za Zhi 93(46): 3698-3702